Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same Treatments

NCT01257139 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

490

Enrollment

OTHER

Sponsor class

Conditions

Non Small-cell Lung Cancer

Interventions

PROCEDURE: Dual-agent therapy or docetaxel alone or best supportive care

Sponsor

Rennes University Hospital